Published date: 19 July 2022
This notice was replaced on 17 July 2023
This notice does not contain the most up-to-date information about this procurement. The most recent notice is:
Awarded contract (published 17 July 2023)
Awarded contract - This means that the contract has been awarded to a supplier.
Contract summary
Industry
Vaccines - 33651600
Location of contract
United Kingdom
Value of contract
£0
Procurement reference
CF-0965500D0O000000rwimUAA1
Published date
19 July 2022
Closing date
18 March 2022
Closing time
1pm
Contract start date
1 August 2023
Contract end date
31 July 2027
Contract type
Supply contract
Procedure type
Open procedure (above threshold)
Any interested supplier may submit a tender in response to an opportunity notice.
This procedure can be used for procurements above the relevant contract value threshold.
Contract is suitable for SMEs?
No
Contract is suitable for VCSEs?
No
Description
The provision of a vaccine to protect against meningococcal disease caused by Neisseria meningitidis groups A, C, W and Y, to be used as part of the national childhood immunisation programme.
The contracting authority estimates their requirement over the period of the contract, including the period of the optional extension to be up to
4.7 million doses of vaccine.
Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.
Award information
Awarded date
18 July 2022
Contract start date
1 August 2023
Contract end date
31 July 2027
Total value of contract
£1
This contract was awarded to 1 supplier.
Aventis Pharma Ltd Trading As Sanofi
Address
410 Thames Valley Park Drive RG6 1PT
Reference
None
Supplier is SME?
No
About the buyer
Contact name
Chantal Jockel
Address
Premier House, 60 Caversham Road
Reading
RG1 7EB
GB
Share this notice